Skip to main content

Table 3 Association between MC and genital HPV detection in men by lifetime number of female partners

From: Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study

  

Circumcision

 

N

No

Yes

   

Univariate

Multivariable1

   

PR (95% CI)

PR (95% CI)

Any HPV

 Lifetime number of female partners

   

P = 0.1462

  1-4

1099

1.00

0.97 (0.87-1.08)

0.92 (0.81-1.03)

  5-12

1183

1.00

0.98 (0.91-1.07)

0.96 (0.88-1.05)

  13+

1083

1.00

1.03 (0.97-1.10)

1.03 (0.96-1.10)

Oncogenic HPV

 Lifetime number of female partners

   

P = 0.2042

  1-4

667

1.00

0.93 (0.73 - 1.19)

0.96 (0.73 - 1.26)

  5-12

726

1.00

0.96 (0.82 - 1.12)

0.92 (0.77 - 1.09)

  13+

697

1.00

1.06 (0.95 - 1.18)

1.06 (0.95 - 1.19)

Non-Oncogenic HPV

 Lifetime number of female partners

   

P = 0.006 2

  1-4

647

1.00

0.62 (0.45 - 0.83)

0.59 (0.42 - 0.83)

  5-12

668

1.00

0.89 (0.74 - 1.07)

0.88 (0.72 - 1.08)

  13+

542

1.00

1.03 (0.88 - 1.20)

1.03 (0.88 - 1.21)

Unclassified HPV

 Lifetime number of female partners

   

P = 0.9522

  1-4

717

1.00

1.24 (1.01 – 1.51)

1.03 (0.82 – 1.28)3

  5-12

527

1.00

1.25 (0.96 – 1.61)

1.15 (0.86 – 1.53)3

  13+

330

1.00

1.19 (0.83 – 1.71)

1.10 (0.74 – 1.62)3

  1. NOTE. PR, prevalence ratio; CI, confidence interval. Numbers in bold correspond to statistically significant point estimates.
  2. 1Adjusted for race, marital status, female sexual partners in past 3–6 months and male anal sexual partners in the past 3 months.
  3. 2Test for interaction between MC and lifetime number of female partners.
  4. 3Adjusted for race, marital status, and male anal sexual partners in the past 3 months.